Horizon Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.00 Cr
- Revenue Growth %
- Profit Growth 68.21%
- Ebitda
- Net Worth -18.59%
- Total Assets -0.31%
About Horizon Formulations
Horizon Formulations Private Limited (HFPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 November 2005 and has a history of 19 years and two months. Its registered office is in Gurdaspur, Punjab, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹3.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajesh Chopra and Gamini Chopra serve as directors at the Company.
Company Details
-
Location
Gurdaspur, Punjab, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51500PB2005PTC029207
-
Company No.
029207
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Nov 2005
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Horizon Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Chopra
|
Additional Director | 04-Mar-2010 | Current |
|
Gamini Chopra
|
Additional Director | 04-Mar-2010 | Current |
Financial Performance of Horizon Formulations.
Horizon Formulations Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 68.21% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Horizon Formulations?
In 2018, Horizon Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Derma Story LimitedRajesh Chopra and Gamini Chopra are mutual person
-
Mefro Pharmaceuticals Pvt Ltd
Rajesh Chopra and Gamini Chopra are mutual person
-
Voodoo Showoff Private Limited
Gamini Chopra is a mutual person
Charges (Loans)
₹0
₹30.00 M
Charges Breakdown by Lending Institutions
- Punjab National Bank : 3.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2013 | Punjab National Bank | ₹3.00 Cr | Satisfied |
How Many Employees Work at Horizon Formulations?
Unlock and access historical data on people associated with Horizon Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Horizon Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Horizon Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
